Home » Blog » Senate Passes SGR Reform Bill; 40th Annual ONS Congress Approaching

Senate Passes SGR Reform Bill; 40th Annual ONS Congress Approaching

IP Blog | Dave Melin | April 19, 2015

BioBlog Weekly oncologyThis week in healthcare, the US Senate passes long-awaited SGR reform legislation and the 40th Annual ONS Congress will focus on the future of oncology care.

Upcoming ONS Congress to Focus on the Future of Oncology Care

This year’s 40th Annual Oncology Nursing Society (ONS) Congress will take a look at the history of oncology care and what lies ahead. The Keynote Address will look at the “transformational leadership” needed to run a successful oncology practice. Other sessions will address current issues and innovations, survivorship care, and new products and treatment options.

Physicians say good riddance to SGR, applaud Senate repeal vote

As physicians applaud the US Senate’s repeal of SGR to avert a 21% payment cut, health care stakeholders reacted, calling the measure a “monumental achievement” and saying that now they “can work toward other elements with Congress, CMS and others, putting patients first, ensuring access to care, looking to reduce overall costs, and improving healthcare quality.”

What the SGR repeal means for value-based payment models

In an expert panel hosted by the National Coalition on Health Care held immediately after the passage of SGR reform bill by the US Senate, analysts stated that “while the ‘doc fix’ bill represents a major step forward, it is only one piece of the healthcare reform puzzle.”

Susan G. Komen® and Walgreens Aim to Cut Breast Cancer Deaths with Millions in New Funds for Patient Navigators in 16 Cities

Walgreens and Susan G. Komen have announced $3 million in new grants aimed at reducing breast cancer deaths across the country. The grants will help patient navigator programs, aimed at medically underserved patients, to “connect patients who have received abnormal breast imaging results with specially trained navigators that can guide them through and around the barriers in the complex cancer care system to ensure timely diagnosis and treatment.”

Has the 340B Program Lost Its Way?

While the 340B program was originally begun to ensure drug access to low-income patients, this articles argues that “today the potential to double-dip on discounts and rebates for 340B drugs is rampant” and says that the program needs an overhaul.

Aetna, Moffitt Cancer Center Form Oncology Medical Home

Recently Aetna and Moffitt Cancer Center of Tampa, Florida announced that they would be collaborating to open an oncology medical home. According to a Moffitt spokesperson, “The oncology medical home will enable Moffitt to provide personalized care to patients that is more effective and efficient.”

Physical Activity Helps Cancer Survivors Fend Off Side Effects

A recent study published in the Journal of Cancer Survivorship has found that “3 or more hours per week of walking helped to improve the hormone functioning and vitality of survivors. … The effect of exercise was even more notable among survivors who walked more than 90 minutes a week at a normal or fast pace, rather than walking at an easier amble.”

Want more health care landscape updates and insights? Follow us on Twitter @innovpartners.

Topics in this Post:

Leave a Comment

Your email address will not be published. Required fields are marked *